Cherington Charles's Form 4 filing
Comera Life Sciences Holdings, Inc. (CMRA) · filed Aug 25, 2023
- Accession no.
- 0001104659-23-095433
- Filed
- Aug 25, 2023
- Trade date
- Jul 31, 2023
- Filing delay
- 25 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $448.9K. It was filed 25 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cherington CharlesCIK 0001448698 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Common Stock | PPurchaseAcquired | +880,195 | $0.51F1 | +$448,899.45 | 3,759,861 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Common Stock | PPurchaseAcquired | +2,200,488 | $0.00F1 | $0 | 2,200,488 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On July 31, 2023, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 880,195 shares of the Issuer's Common Stock and Warrants to purchase up to 2,200,488 shares of Common Stock. The combined purchase price per share of Common Stock and accompanying Warrant in the offering was $0.51125, with all of the purchase price allocated to the shares of Common Stock.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.